Case study: Biotech firm Cytiva hardens physical security
With a rich heritage in biotech, Cytiva provides technologies and services that advance and accelerate the development and manufacturing of therapeutics.
Operating in over 40 countries worldwide, the company conducts fundamental biological research and develops pioneering vaccines, biologic drugs and novel cell and gene therapies. With over 100 locations globally, Cytiva knows that shaping the future of life sciences requires a firm grip on all aspects of security.